What Happened?
Boston, MA-based Regina Paglia as Senior Vice President of Human Resources
About the Company
Paratek Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. Its lead product candidate, omadacycline, is a tetracycline-derived and broad-spectrum antibiotic developed in oral tablet and intravenous formulations for use as a monotherapy antibiotic for acute bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), urinary tract infections, and other serious community-acquired bacterial infections. The company has special protocol assessment agreements with Food and Drug Administration for the Phase III trials planned in ABSSSI and CABP. It is also developing sarecycline, a tetracycline-derived compound that is in Phase III clinical trials for use in the treatment of acne and rosacea. The company has collaborative research and license agreement with Actavis to research, develop, and commercialize tetracycline products; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and collaboration agreement with Purdue Pharmaceuticals L.P. to commercialize Intermezzo. Paratek Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
About the Person
Regina DeTore Paglia is the Senior Vice President of Human Resources at Paratek Pharmaceuticals, Inc. Ms. Paglia previously held the position of Senior Vice President, Human Resources at Myriant Corporation, a Bio-Chemical Company, where she led initiatives aimed at creating an optimal corporate culture for employee recruitment and retention, such as reward systems, benefits, professional development and other policies. In this capacity, Ms. Paglia also designed and introduced a branded Mission and Core Values initiative for the newly appointed CEO to define organizational direction and enhance employee engagement. Prior to her experience at Myriant, Ms. Paglia served as Vice President, Human Resources for Mascoma Corporation, a Bio-Energy organization. In this role, she focused on strategies to optimize corporate culture and organizational effectiveness, led the CEO search and was responsible for facilitating a successful transition. Ms. Paglia was also Senior Vice President, Human Resources at Sepracor Pharmaceutical, Inc., now Sunovion Pharmaceuticals, where she led HR Organizational initiatives to scale-up for commercialization. Among her many responsibilities, she crafted strategy for four national sales force expansions to source and hire more than 1,800 pharmaceutical sales professionals. Ms. DeTore Paglia holds a Bachelor of Science Degree in Business from Boston, MA-based Suffolk University and a Master of Arts Degree in Human Resource Management from Framingham State University in Framingham, Massachusetts.
Info Source
News
Short Profile